| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |